Please login to the form below

Not currently logged in
Email:
Password:

Dr Ian Hudson elected vice chair of CHMP

Will serve a three-year term on EMA's scientific advisory committee

MHRA CHMP Dr Ian HudsonThe EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as its vice chair for a three-year term.

Dr Hudson has been a member of the scientific advisory committee since 2004 and is currently director of the licensing division at UK medicines regulator the MHRA.

Announcing its appointment the EMA said: “Dr Hudson brings outstanding experience and expertise from a long career in regulatory medicine and drug development, particularly in the areas of anti-infectives and oncology.”

Before joining the MHRA in 2001 Dr Hudson worked in the pharmaceutical industry for 12 years, during which time he held various clinical research and development positions at SmithKline Beecham. Prior to this he worked in clinical practice as a paediatrician.

22nd October 2012

From: Research, Sales, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics